Skip to content
★ Sign in to follow
ESA MEDIKA MANDIRI Tbk, PT logo

ESA MEDIKA MANDIRI Tbk, PT Stock: price and insider trades · Indonesia

ID·Mcap IDR 697.1BHealth Care

1 insider bought €1.0M of shares over the last 90 days, the latest by YULIE SEKURITAS INDONESIA TBK, filed 05 Nov 2026.

ESA MEDIKA MANDIRI Tbk, PT: what insiders have been doing

ESA MEDIKA MANDIRI Tbk, PT is a Health Care company. Its directors and officers file their transactions with OJK / IDX. Between 6 November 2025 and 6 November 2026, 1 insider published 25 filings.

Not one open-market sale was filed. On the buying side, 1 insider reported 25 purchases totalling €4.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Those buying include 1 major shareholder. At €2.5M, the purchase published on 13 July 2026 by Yulie Sekuritas Indonesia Tbk is the largest of the period.

For context, the typical company on the same exchange (median of 317 companies) published 3 filings over the same period, against 25 filings here. The full history, which starts in 2026, counts 25 purchases against no sales.

The most recent open-market purchase was published on 5 November 2026, 3 days ago. Filings reach the OJK / IDX feed a median of 1 day after the trade. Until a filing is published, the market cannot know about the trade.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Source: insider filings from OJK / IDX. Past trades are no guide to future returns.

Insider Decl.
25
Thresholds
n/a
Buy Volume
€4M
25 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Yulie Sekuritas Indonesia Tbk25 buys

Since the insiders bought

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

· cache

IDR 400.00
Analyst consensus
·
Income statement
EBITDAIDR 11.4B
Valuation
P/Book2.1x
Balance sheet & cash
Market capIDR 697.1B
Debt / Equity61%
Profitability & ownership
ROE29.7%
ROA6.5%
% insiders81.0%
% institutions0.0%
Last declaration on 5 November 2026
Declarations25 total
  • ▲
    Related company / holdingExecutives
    9B IDR19IDX
    21,950,000 shares@ IDR 430.001.34% mcap11.0% of flowCommon SharesIDXIDX:LK-05112026-0010-1#0
    Canonical exit: 2 Feb 2027 (T+90)
  • ▲
    Related company / holdingExecutives
    9B IDR19IDX
    21,114,800 shares@ IDR 425.001.27% mcap10.4% of flowCommon SharesIDXIDX:LK-05112026-0010-1#1
    Canonical exit: 2 Feb 2027 (T+90)
  • ▲
    Related company / holdingExecutives
    14M IDR5IDX
    35,200 shares@ IDR 388.000.0019% mcap0.0% of flowCommon SharesIDXIDX:LK-05112026-0010-1#2
    Canonical exit: 2 Feb 2027 (T+90)
  • ▲
    Related company / holdingExecutives
    9M IDR5IDX
    22,800 shares@ IDR 390.000.0013% mcap0.0% of flowCommon SharesIDXIDX:LK-05112026-0010-1#3
    Canonical exit: 2 Feb 2027 (T+90)
  • ▲
    Related company / holdingExecutives
    8M IDR5IDX
    21,500 shares@ IDR 394.000.0012% mcap0.0% of flowCommon SharesIDXIDX:LK-05112026-0010-1#4
    Canonical exit: 2 Feb 2027 (T+90)
  • ▲
    Related company / holdingExecutives
    284M IDR9IDX
    700,000 shares@ IDR 406.000.040% mcap0.3% of flowCommon SharesIDXIDX:LK-05112026-0010-1#5
    Canonical exit: 2 Feb 2027 (T+90)
  • ▲
    Related company / holdingExecutives
    87M IDR7IDX
    218,100 shares@ IDR 398.000.012% mcap0.1% of flowCommon SharesIDXIDX:LK-05112026-0010-1#6
    Canonical exit: 2 Feb 2027 (T+90)
  • ▲
    Related company / holdingExecutives
    93M IDR7IDX
    232,700 shares@ IDR 400.000.013% mcap0.1% of flowCommon SharesIDXIDX:LK-05112026-0010-1#7
    Canonical exit: 2 Feb 2027 (T+90)
  • ▲
    Related company / holdingExecutives
    84M IDR7IDX
    209,000 shares@ IDR 402.000.012% mcap0.1% of flowCommon SharesIDXIDX:LK-05112026-0010-1#8
    Canonical exit: 2 Feb 2027 (T+90)
  • ▲
    Related company / holdingExecutives
    33M IDR5IDX
    82,900 shares@ IDR 404.000.0048% mcap0.0% of flowCommon SharesIDXIDX:LK-05112026-0010-1#9
    Canonical exit: 2 Feb 2027 (T+90)
  • ▲
    Related company / holdingExecutives
    21M IDR5IDX
    53,900 shares@ IDR 396.000.0030% mcap0.0% of flowCommon SharesIDXIDX:LK-05112026-0010-1#10
    Canonical exit: 2 Feb 2027 (T+90)
  • ▲
    Related company / holdingExecutives
    1B IDR21IDX
    2,795,100 shares@ IDR 397.002.71% mcap1.7% of flowCommon SharesIDXIDX:LK-21102026-0007-1#0
    Canonical exit: 17 Jan 2027 (T+90)
  • ▲
    Related company / holdingExecutives
    325M IDR19IDX
    779,800 shares@ IDR 417.000.82% mcap0.5% of flowCommon SharesIDXIDX:LK-21102026-0007-1#1
    Canonical exit: 18 Jan 2027 (T+90)
  • ▲
    Related company / holdingExecutives
    106M IDR15IDX
    295,600 shares@ IDR 360.000.27% mcap0.2% of flowCommon SharesIDXIDX:LK-11092026-0002-1#8
    Canonical exit: 9 Dec 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    39M IDR13IDX
    112,400 shares@ IDR 350.000.10% mcap0.1% of flowCommon SharesIDXIDX:LK-11092026-0002-1#0
    Canonical exit: 8 Dec 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    23M IDR11IDX
    64,800 shares@ IDR 352.000.058% mcap0.0% of flowCommon SharesIDXIDX:LK-11092026-0002-1#1
    Canonical exit: 8 Dec 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    94M IDR15IDX
    264,700 shares@ IDR 354.000.24% mcap0.1% of flowCommon SharesIDXIDX:LK-11092026-0002-1#2
    Canonical exit: 8 Dec 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    160M IDR16IDX
    450,000 shares@ IDR 356.000.41% mcap0.3% of flowCommon SharesIDXIDX:LK-11092026-0002-1#3
    Canonical exit: 8 Dec 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    54M IDR13IDX
    150,000 shares@ IDR 358.000.14% mcap0.1% of flowCommon SharesIDXIDX:LK-11092026-0002-1#4
    Canonical exit: 8 Dec 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    144M IDR16IDX
    400,000 shares@ IDR 360.000.37% mcap0.2% of flowCommon SharesIDXIDX:LK-11092026-0002-1#5
    Canonical exit: 8 Dec 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    41M IDR13IDX
    115,900 shares@ IDR 356.000.11% mcap0.1% of flowCommon SharesIDXIDX:LK-11092026-0002-1#6
    Canonical exit: 9 Dec 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    37M IDR12IDX
    104,400 shares@ IDR 358.000.095% mcap0.1% of flowCommon SharesIDXIDX:LK-11092026-0002-1#7
    Canonical exit: 9 Dec 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    9B IDR8IDX
    18,586,900 shares@ IDR 468.0020.35% mcap13.5% of flowCommon SharesIDXIDX:LK-17072026-0006-1#0
    Canonical exit: 14 Oct 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    50B IDR15IDX
    106,838,100 shares@ IDR 470.0077.8% of flowCommon SharesIDXIDX:LK-13072026-0007-1#0
    Canonical exit: 7 Oct 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    5B IDR8IDX
    10,200,000 shares@ IDR 494.0011.44% mcap7.6% of flowCommon SharesIDXIDX:LK-13072026-0007-1#1
    Canonical exit: 8 Oct 2026 (T+90)

25 of 25 declarations

About ESA MEDIKA MANDIRI Tbk, PT

ESA MEDIKA MANDIRI Tbk, PT is a publicly traded company on the XIDX market, specializing in the healthcare sector in Indonesia.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations